Sunshine Biopharma: Funding, Investors & Team (Sep 2026)
Sunshine Biopharma specializes in studying, creating, and marketing medications for different types of cancer. The ongoing COVID-19 pandemic, caused by the virus SARS-CoV-2, has resulted in the deaths of over 4 million individuals globally since it emerged in December 2019. There are currently no effective drugs available to stop the virus's replication in infected individuals.
Sunshine Biopharma has raised $8.5M across 2 funding rounds on record, the most recent an undisclosed round of $6.0M announced in May 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Sunshine Biopharma Company Profile and Key Stats
Latest funding round on record: May 2026.
Sunshine Biopharma Funding Rounds
Sunshine Biopharma raised $2.5M in an undisclosed round announced in Apr 2025.
1.1 years later, an undisclosed round of $6.0M was announced in May 2026.
Sunshine Biopharma Founders and Leadership Team
Contact details for the Sunshine Biopharma team: 1 of 1 has an email address on file.
Start 14-day free trial →Sunshine Biopharma Funding Compared to Other Biotechnology Startups
Sunshine Biopharma's latest round of $6.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Sunshine Biopharma in Biotechnology and Fort Lauderdale
Companies Similar to Sunshine Biopharma
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Sunshine Biopharma Funding FAQs
What does Sunshine Biopharma do?
Sunshine Biopharma specializes in studying, creating, and marketing medications for different types of cancer. The ongoing COVID-19 pandemic, caused by the virus SARS-CoV-2, has resulted in the deaths of over 4 million individuals globally since it emerged in December 2019. There are currently no effective drugs available to stop the virus's replication in infected individuals.
How much funding has Sunshine Biopharma raised?
Sunshine Biopharma has raised $8.5M across 2 rounds on record. The most recent is an undisclosed round of $6.0M announced in May 2026.
When did Sunshine Biopharma last raise funding?
Sunshine Biopharma's most recent funding round on record is an undisclosed round of $6.0M, announced in May 2026.
Who founded Sunshine Biopharma?
FundedIQ lists Steve Slilaty (Founder) at Sunshine Biopharma.
Where is Sunshine Biopharma headquartered?
Sunshine Biopharma is based in Fort Lauderdale, Florida, United States.
How many employees does Sunshine Biopharma have?
Sunshine Biopharma is in the 1-10 employee band.
How does Sunshine Biopharma's funding compare to other Biotechnology startups?
Sunshine Biopharma's latest round of $6.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Sunshine Biopharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Sunshine Biopharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.